Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest update is out from IQVIA Holdings ( (IQV) ).
On November 5, 2025, IQVIA Holdings Inc. announced the appointment of Dr. William G. Kaelin Jr. to its Board of Directors. Dr. Kaelin, a Nobel Prize-winning scientist with extensive expertise in oncology and biomedical innovation, is expected to enhance the board’s capabilities. This strategic appointment is likely to strengthen IQVIA’s industry positioning by leveraging Dr. Kaelin’s scientific expertise and leadership experience, potentially benefiting stakeholders through advanced insights and innovation in healthcare solutions.
The most recent analyst rating on (IQV) stock is a Hold with a $215.00 price target. To see the full list of analyst forecasts on IQVIA Holdings stock, see the IQV Stock Forecast page.
Spark’s Take on IQV Stock
According to Spark, TipRanks’ AI Analyst, IQV is a Outperform.
IQVIA’s strong financial performance and positive earnings call sentiment are the most significant factors driving the overall score. The company’s robust cash flow and strategic focus on AI and technology advancements suggest potential for future growth. However, the high P/E ratio and absence of a dividend yield weigh on the valuation, and technical indicators suggest caution due to nearing overbought conditions.
To see Spark’s full report on IQV stock, click here.
More about IQVIA Holdings
IQVIA is a leading global provider of clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries. The company leverages high-quality health data, AI, advanced analytics, and extensive domain expertise to deliver actionable insights and services. With approximately 91,000 employees in over 100 countries, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to improve patient outcomes and population health worldwide.
Average Trading Volume: 1,423,173
Technical Sentiment Signal: Buy
Current Market Cap: $35.93B
Learn more about IQV stock on TipRanks’ Stock Analysis page.